Radiopharm Theranostics Limited Adjustments For Share-based Payments
Radiopharm Theranostics Limited (RADX) reported Adjustments For Share-based Payments of $1.90 million for the 12-month period ending 2025-06-30, per its 20-F filed 2025-09-18.
Financial Statements › Notes › Compensation Related Costs
ifrs-full:AdjustmentsForSharebasedPayments · last filed 2025-09-18
| Period end | Adjustments For Share-based Payments 12 month |
|---|---|
| 2025-06-30 | $1.90M 20-F · filed 2025-09-18 |
| 2024-06-30 | $2.64M 20-F · filed 2025-09-18 |
| 2023-06-30 | $3.04M 20-F · filed 2025-09-18 |